Search

Your search keyword '"Correale, Michele"' showing total 1,023 results

Search Constraints

Start Over You searched for: Author "Correale, Michele" Remove constraint Author: "Correale, Michele"
1,023 results on '"Correale, Michele"'

Search Results

2. Effect of sacubitril/valsartan on cardiac remodeling compared with other renin–angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samples

6. Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunction

9. Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus

12. Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension

20. Pleiotropic Effects of Direct Oral Anticoagulants in Chronic Heart Failure and Atrial Fibrillation: Machine Learning Analysis

21. Combined peripheral and central ultrasound for the diagnosis of PAH‐SSc patients

22. Combined peripheral and central ultrasound for diagnosis of PAH-SSc patients.

23. Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fraction

25. Pick Your Threshold: A Comparison Among Different Methods of Anaerobic Threshold Evaluation in Heart Failure Prognostic Assessment

26. Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology

28. Circulating biomarkers in pulmonary arterial hypertension : an update

30. Relevance of Echocardiography-derived Phenotyping in Patients with Pulmonary Arterial Hypertension Treated with Initial Oral Combination Therapy: An Italian Pulmonary Hypertension Network (iPHNET) Study.

31. Distinct Profiles and New Pharmacological Targets for Heart Failure with Preserved Ejection Fraction.

33. Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond

35. Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension

36. Cardiovascular Death Risk in Recovered Mid-Range Ejection Fraction Heart Failure: Insights From Cardiopulmonary Exercise Test

39. Endothelial Function in Pulmonary Arterial Hypertension: From Bench to Bedside.

43. Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group

44. Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure

45. Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban

46. Pharmacoutilization and adherence to sacubitril/valsartan in real world: the REAL.IT study in HFrEF

49. Switch to gliflozins and biventricular function improvement in patients with chronic heart failure and diabetes mellitus

50. What about chronotropic incompetence in heart failure with mildly reduced ejection fraction? Clinical and prognostic implications from the Metabolic Exercise combined with Cardiac and Kidney Indexes score dataset

Catalog

Books, media, physical & digital resources